ArticleJournal of managed care & specialty pharmacy2025
The impact of patient characteristics and social drivers of health factors on oral oncolytic adherence.
Article in Journal of managed care & specialty pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Effectiveness of Mobile Health for Improving Medication Adherence in Patients With Cancer: Systematic Review and Meta-Analysis of Randomized Controlled Trials.Journal of medical Internet research · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOral oncolytic medication adherence is crucial for effective cancer treatment, yet adherence rates vary widely (16%-100%) depending on cancer subtypes, assessment methodologies, and patient contexts. The increased use of oral medications for various cancer types, although often advantageous over traditional parenteral infusions, has transferred the responsibility of medication administration and management to patients. As such, Stanford Specialty Pharmacy uses a team of pharmacists and liaisons who proactively follow-up with patients before each refill to track adherence and make recommendations where required. Although this program is a step forward in bettering patient outcomes, it does not address the root cause of medication nonadherence. It is vital to better understand trends associated with oral oncolytic medication adherence to better support patients with adherence.
objectiveTo conduct a retrospective analysis of patient records at Stanford Health Care (SHC) Specialty Pharmacy to probe correlations between patient characteristics, social determinants and drivers of health, and adherence to oral oncolytic medications to better support patients with their medication adherence.
methodsThis population included patients aged at least 18 years who had an oral oncolytic dispensed from SHC Specialty Pharmacy between May 2022 and April 2023, with patient characteristics and adherence data taken from patients' electronic health records. Medication nonadherence was defined as a proportion of days covered less than 80%. Using multivariable mixed-effects logistic regression, the rate of nonadherence was compared across several patient characteristics, including age, race and ethnicity, and geographic residence.
resultsAmong 939 patients, 73.75% demonstrated medication adherence, highlighting a high adherence rate within the SHC Specialty Pharmacy cohort. Smoking was significantly associated with 395% higher odds of nonadherence (95% CI = 1.07 - 14.6; P = 0.04) compared with smoking abstinence, whereas patients with obesity presented 59% lower odds of nonadherence compared with patients with normal weight (95% CI = 0.24-0.69; P < 0.001). Additionally, trends in primary language, race and ethnicity, and geographic residence in relation to medication adherence were seen.
conclusionsThese findings show multiple patient characteristics that are associated with oral oncolytic adherence. These identified patterns and additional studies will better inform targeted interventions for achieving equitable care and enhancing access to effective cancer treatments, leading to improved patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.